Gun jumping: The European Commission issues a final statement of objections alleging that a pharmaceutical company has prematurely acquired one of its competitors in violation of Article 7 of the Merger Regulation (Illumina / Grail)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. The Commission was quick to react! Only a few days after the adoption, on July 13, 2022, by the European Court of First Instance of the judgment in case T-227/21 (Illumina, Inc. v. European Commission) which upheld the Commission's decisions accepting a

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • L’actu-concurrence (Paris)

Quotation

Alain Ronzano, Gun jumping: The European Commission issues a final statement of objections alleging that a pharmaceutical company has prematurely acquired one of its competitors in violation of Article 7 of the Merger Regulation (Illumina / Grail), 19 July 2022, Concurrences N° 3-2022, Art. N° 107709, www.concurrences.com

Visites 172

All reviews